益氣健脾活血方聯(lián)合化療對(duì)中晚期胃癌患者QOL影響的臨床研究.pdf

1、南京中醫(yī)藥大學(xué)碩士學(xué)位論文益氣健脾活血方聯(lián)合化療對(duì)中晚期胃癌患者QOL影響的臨床研究姓名：白明貴申請(qǐng)學(xué)位級(jí)別：碩士專業(yè)：中醫(yī)內(nèi)科學(xué)腫瘤指導(dǎo)教師：灑榮桂20090701ABSTRACTobjective：ToobserveYiqijianpihuoxuecombinedwithchemicaltherapy仃eatinggastriccallceronthequalityoflife，andevaluatethecurativeeffec

2、tandadvantageofyiqijianpihuoxueinadvancedgastriccancerProvidingclinicaledvidenceforChinesemedicinespreadandappliedinadvancedgastriccancerandothermalenantcarcinomaMethods：47caseswithadvancedgastriccancerrandomlydividedint

3、otwogroups，thetreatmentgroup(YiqijianpihuoxuecombinedwithchemotherapymDCF)with24cases，thecontrolgroup(chemotherapyalonemDCF)witll23cases，nletreatmentgroupwithmDCFconventionalchemotherapy，and21daysasacourseofcontinuousobs

4、ervationfor2cyclesChemotherapytreatmentgroup、ⅣithYiqijianpihuoxuefororaltakenonceadayintheinterimperiodComparedtwogroupsinchangesintumorlesions，qualityoflife，andtheimprovementofsymptomsChinesesituationResults：(堇_)compari

5、soninTumorsize：thereisnosignificantdifferenceinbothgroups(P005)②comparisoninQualityoflife：comparetheimprovementofEORTCQLQC30gradesbetweenthetwogroups，Thereissignificantimprovementofdailyactivities，emotions，activity(PO05)

6、inthecontrolgroup，significantimprovementinallaspectsinthetreatmentgroup(PO05)⑨comparisoninSymptomsofTcMimprovement：Inthetreatmentgroup5Casesweremarkedeffect，10caseswereeffect，thetotaleffectiverateup75％；inthecontrolgroup，

7、3Casesweremarkedeffect，4caseswereeffect，thetotaleffectiverateonly333％，thereissignificantdifferenceinthetwogroups(PO01)@ComparisoninphysicalconditionKamorfsyscoreofthetwogroupswerebothimprovedaftertreatmentThereisstatisti

8、callysignificantdifferencebetweenthetwogroupsaftertreatment(P005)Conclusion：①YiqijianpihuoxuecombinedwithchemotherapymDCFcanimprovetheSymptomsofTCMandqualityoflifeofthepatientswithadvancedgastricCanCer②furtherupshowedtha